Vogt-Koyanagi-Harada-Syndrome Concurrent with Morbus Darier
Journal Title: Journal of Rheumatic Diseases and Treatment - Year 2016, Vol 2, Issue 2
Abstract
Vogt-Koyanagi-Harada-syndrome (VKH) is a multisystemic, T-cell mediated autoimmune disorder which is characterized by bilateral granulomatous panuveitis with extraocular manifestations in the central nervous and auditory system as well as in the integumentary field. Neurological and auditory manifestations include aseptic meningitis, meningism, tinnitus and cerebrospinal fluid pleocytosis. Integumentary findings can include alopecia, poliosis and vitiligo. The etiology of this disease is thought to be an immune reaction against melanocytes.
Authors and Affiliations
Keywords
Related Articles
- EP ID EP348753
- DOI 10.23937/2469-5726/1510036
- Views 116
- Downloads 0
SLE - Update Ethiopathogenesis Leading to Biological Therapy
Systemic lupus erythematosus is a chronic, autoimmune disorder which may have even fatal consequences, particularly if it affects vital organs of the human body. It is typically manifested by inflammation of various orga...
TB: Falsely Accused? (A Case Report and Discussion)
Interferon-Gamma Release Assays (IGRAs) in the past decade have become ubiquitous screening for tuberculosis (TB). Development of these interferon release tests helped screen for TB in patients at high risk, specifically...
Scleroderma Renal Crisis
Scleroderma or Systemic sclerosis is a vascular and fibrotic disease with organ-based complications and high mortality and morbidity. Renal involvement can be quite varied and scleroderma renal crisis is the most severe...
Is There a Correlation Between DAS28/RADAI in a Cohort of Rheumatoid Arthritis Patients Treated with Biological Therapy
Aim: To describe the degree of activity of RA patients receiving biological agents co-monitored by rheumatologist and nurses. To assess RA activity using validated methods: DAS28, RADAI, visual analog scales (VAS), and t...
Role of Strontium Ranelate in the Therapy of Osteoporosis
Strontium ranelate is a medicine used to treat postmenopausal osteoporosis in women and osteoporosis in men. Preclinical data suggest its dual effect consisting of the control of bone resorption and promotion of bone for...